Clinical Trial Update: Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

View source ↗

Summary

A completed clinical trial assessed lacosamide (VIMPAT) as adjunctive therapy for adults with partial-onset seizures; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Seizures | Status: COMPLETED | Results posted: 2013-08-08